sulfathiazole, sulfacetamide and sulfabenzamide

North America

Canada (0)
No result.
United States (10)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
GYNE-SULF 3.7%;2.86%;3.42% cream
N
vaginal
X000135
SULTRIN 184MG;143.75MG;172.5MG tabs
N
vaginal
X000135
SULTRIN 3.7%;2.86%;3.42% cream
N
vaginal
X000135
TRIPLE SULFA 184MG;143.75MG;172.5MG tabs
N
vaginal
X000135
TRIPLE SULFA 184MG;143.75MG;172.5MG tabs
N
vaginal
X000135
TRIPLE SULFA 3.7%;2.86%;3.42% cream
N
vaginal
X000135
TRIPLE SULFA 3.7%;2.86%;3.42% cream
N
vaginal
X000135
TRIPLE SULFA 3.7%;2.86%;3.42% cream
N
vaginal
X000135
TRYSUL 3.7%;2.86%;3.42% cream
N
vaginal
X000135
VAGILIA 3.7%;2.86%;3.42% cream
N
vaginal
X000135
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
GYNE-SULF 3.7%;2.86%;3.42% cream
88607/1
ANDA
09-06-1986
SULTRIN 184MG;143.75MG;172.5MG tabs
5794/2
NDA
01-01-1982
SULTRIN 3.7%;2.86%;3.42% cream
5794/1
NDA
01-01-1982
TRIPLE SULFA 184MG;143.75MG;172.5MG tabs
88463/1
ANDA
03-01-1985
TRIPLE SULFA 184MG;143.75MG;172.5MG tabs
88462/1
ANDA
03-01-1985
TRIPLE SULFA 3.7%;2.86%;3.42% cream
87864/1
ANDA
01-09-1982
TRIPLE SULFA 3.7%;2.86%;3.42% cream
86424/1
ANDA
01-01-1982
TRIPLE SULFA 3.7%;2.86%;3.42% cream
87285/1
ANDA
15-11-1982
TRYSUL 3.7%;2.86%;3.42% cream
87887/1
ANDA
23-07-1982
VAGILIA 3.7%;2.86%;3.42% cream
88821/1
ANDA
09-11-1987
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Europe

Austria (0)
No result.
Belgium (0)
No result.
Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (0)
No result.
Lithuania (0)
No result.
Malta (0)
No result.
Norway (0)
No result.
Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (0)
No result.